CP and Alzheimer disease: Despite its importance and in contrast to our detailed knowledge regarding the endocytosis of GluA2-containing CI-AMPARs, the mechanisms and molecular determinants that control the surface levels of GluA1-homomeric CP-AMPARs during long-term plastic changes of synaptic strength and in AD are largely unknown (Fig. 1A).